Ellingwood, Beth
Ellingwood, Beth was paid $614K by Medicaid between Jan 2018 and Mar 2023, across 32 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoELLINGWOOD, BETH
NORTH ADAMS, MA 01247
NORTH ADAMS, MA 01247
33aNPI1326000738assigned 04/03/2006
33bProvider typeSpecialist
28Total paid$614K
24GClaims15,485
24DCodes billed32
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Specialist providers in Massachusetts
Rank by total paid#26 of 179
Median peer was paid$23K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,362 | $87K | |
| 2019 | 2,757 | $99K | |
| 2020 | 3,178 | $126K | |
| 2021 | 3,057 | $120K | |
| 2022 | 3,499 | $155K | |
| 2023 | 632 | $27K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 1,910 | 1,863 | $177K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 2,843 | 2,740 | $155K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11% | 2,007 | 1,621 | $65K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.1% | 725 | 714 | $37K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.3% | 395 | 395 | $33K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 3.5% | 2,409 | 2,403 | $22K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.9% | 221 | 221 | $18K |
| 96127 | 2.7% | 1,319 | 1,262 | $17K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.2% | 145 | 145 | $13K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.2% | 1,136 | 1,126 | $13K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.9% | 146 | 145 | $12K |
| 90461 | 1.8% | 299 | 299 | $11K |
20 more codes
| 99177 | 1.1% | 248 | $7K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 220 | $5K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 51 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 312 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 113 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 133 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 137 | $3K |
| 92558 | <1% | 186 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 201 | $2K |
| 0002A | <1% | 43 | $2K | |
| 0071A | <1% | 40 | $2K | |
| 0001A | <1% | 22 | $1K | |
| 99051 | <1% | 57 | $943.92 | |
| 0154A | <1% | 14 | $642.32 | |
| 99173 | <1% | 25 | $555.50 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 30 | $473.06 |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | <1% | 17 | $136.00 |
| 85018 | <1% | 51 | $113.80 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 17 | $41.65 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $21.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.